Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 1/2 6Phase 2 5Phase 3 2Phase 2/3 1

Status

Completed 3Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 5

Conditions

Carcinoma, Non-Small-Cell Lung 687Breast Neoplasms 585Neoplasms 468Colorectal Neoplasms 300Prostatic Neoplasms 263Neoplasm Metastasis 257Melanoma 242Ovarian Neoplasms 228Recurrence 216Lung Neoplasms 203Multiple Myeloma 196Lymphoma, Non-Hodgkin 155Pancreatic Neoplasms 154Leukemia, Myeloid, Acute 142Carcinoma, Hepatocellular 141Stomach Neoplasms 137Lymphoma 131Carcinoma, Renal Cell 128Glioblastoma 118Squamous Cell Carcinoma of Head and Neck 113Head and Neck Neoplasms 113Lymphoma, Follicular 106Leukemia, Lymphocytic, Chronic, B-Cell 99Small Cell Lung Carcinoma 96Lymphoma, Large B-Cell, Diffuse 96Leukemia 96Brain Neoplasms 91Carcinoma 82Uterine Cervical Neoplasms 77Triple Negative Breast Neoplasms 73

Interventions

Docetaxel 2Nivolumab 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × INDUSTRY × Advanced Non-small Cell Lung Cancer × Clear all
NCT05420220 2026-05-28

Study of KN046 in Subjects With Advanced Non-Small Cell Lung Cancer

Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Phase 2 Completed
95 enrolled
Thoracic

Advanced Non-small Cell Lung Cancer

NCT02582125 2025-03-24

ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer

Ono Pharmaceutical Co., Ltd.

Phase 2 Completed
53 enrolled
Thoracic

Advanced Non-small Cell Lung Cancer

NCT05215067 2025-03-12

A Phase II Trial of AK104 in Advanced Non-Small Cell Lung Cancer

Akeso

Phase 2 Active not recruiting
44 enrolled
Thoracic

Advanced Non-small Cell Lung Cancer

NCT06775483 2025-01-15

Evaluation of JSKN016 in the Treatment of Advanced Non-small Cell Lung Cance: a Phase II Clinical Study

Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Phase 2 Not yet recruiting
220 enrolled
Thoracic

Advanced Non-small Cell Lung Cancer

NCT03693547 2023-01-10

Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer(NSCLC)

Beijing Biostar Pharmaceuticals Co., Ltd.

Phase 2 Completed
26 enrolled
Thoracic

Advanced Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡